{"id":"W3031930276","doi":"10.1200/jco.2020.38.15_suppl.5002","title":"SAVOIR: A phase III study of savolitinib versus sunitinib in pts with MET-driven papillary renal cell carcinoma (PRCC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Sunitinib; Medicine; Tolerability; Internal medicine; Oncology; Renal cell carcinoma; Adverse effect; Papillary renal cell carcinomas; Expanded access; Tyrosine-kinase inhibitor; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Urology; Clinical trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001947189,0.001443137,0.002210532,0.0003750864,0.0003780087,0.001135992,0.001316521,0.001549933,0.006385881],"category_scores_gemma":[0.001162669,0.0007092542,0.001964531,0.0003200193,0.0007939069,0.001079,0.0004051601,0.003432565,0.001474371],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009257208,"about_ca_system_score_gemma":0.001464599,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009594361,"about_ca_topic_score_gemma":0.00322552,"domain_scores_codex":[0.9994981,0.0002628286,0.00002569137,0.00008277315,0.00004787966,0.0000825962],"domain_scores_gemma":[0.9992963,0.0001239782,0.0001371133,0.00006044424,0.00006087162,0.0003212364],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8700012,0.0426221,0.003368337,0.00127027,0.001732278,0.0001633,0.0003334753,0.001641889,0.02261689,0.0003170534,0.003711654,0.05222153],"study_design_scores_gemma":[0.7593492,0.2317322,0.004222687,0.00003555286,0.0003903793,0.0001585931,0.00006274199,0.001022417,0.001159076,0.0002038855,0.0016414,0.00002183549],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9866208,0.002577964,0.0008809442,0.0006739207,0.0002756568,0.004108505,0.001603494,0.0002504485,0.003008266],"genre_scores_gemma":[0.9869552,0.001421693,0.001748085,0.001005484,0.0001693728,0.003085673,0.001953047,0.00004413498,0.003617243],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006385881,"threshold_uncertainty_score":0.02136296,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2340272204355645,"score_gpt":0.4389662506684173,"score_spread":0.2049390302328528,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}